Gage, B. F., Eby, C. S., Johnson, J. A., Rieder, M. J., Ridker, P. M., Rettie, A. E., … McLeod, H. L. (2005). Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. In BLOOD (Vol. 106, pp. 164A-164A). Atlanta, GA: AMER SOC HEMATOLOGY.

Gage, B. F., C. S. Eby, J. A. Johnson, M. J. Rieder, P. M. Ridker, A. E. Rettie, C. Aquilante, et al. “Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.” In BLOOD, 106:164A-164A. AMER SOC HEMATOLOGY, 2005.

Gage BF, Eby CS, Johnson JA, Rieder MJ, Ridker PM, Rettie AE, et al. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. In: BLOOD. AMER SOC HEMATOLOGY; 2005. p. 164A-164A.

Gage, B. F., et al. “Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.” BLOOD, vol. 106, no. 11, AMER SOC HEMATOLOGY, 2005, pp. 164A-164A.

Gage BF, Eby CS, Johnson JA, Rieder MJ, Ridker PM, Rettie AE, Aquilante C, Milligan PE, Marsh S, Voora D, Langaee T, Veenstra DL, Birman-Deych E, Glynn R, Nickerson DA, McLeod HL. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. BLOOD. AMER SOC HEMATOLOGY; 2005. p. 164A-164A.